Back
HFA Premium Access

The role of soluble st2 and galectin-3 in hypertrophic cardiomyopathy assessed by cardiac magnetic resonance

Session: Poster Session 4 - Hypertrophic cardiomyopathy
Topic: Hypertrophic cardiomyopathy
Speaker: Doctor M. Gawor (Warsaw, PL)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

About the speaker

Doctor Monika Gawor

Institute of Cardiology, Warsaw (Poland)
0 follower

5 more presentations in this session

Predictors of ICD-related adverse events in patients with hypertrophic cardiomyopathy

Speaker: Mr C. Klein (Lille, FR)

Access
Slides
Thumbnail

Impact of hypertrophy in left ventricular ejection fraction and myocardial strain: application of three-dimensional wall-motion tracking technology in hypertrophic cardiomyopathy

Speaker: Doctor L. Marques (Sra. da Hora, PT)

Access
Abstract
Thumbnail

Assessment of left ventricular strain by three-dimensional wall-motion tracking technology: a study in hypertrophic cardiomyopathy

Speaker: Doctor L. Marques (Sra. da Hora, PT)

Access
Abstract
Thumbnail

Brain natriuretic peptide level in patients with hypertrophic cardiomyopathy

Speaker: Mrs A. Demkina (Moscow, RU)

Access
Abstract
Slides
Thumbnail

Myosin heavy chain and MAP-kinase activating death domain-containing gene polymorphisms in adults with hypertrophic cardiomyopathy

Speaker: Miss A. Polyakova (Saint Petersburg, RU)

Access
Slides
Thumbnail

Access the full session

Poster Session 4 - Hypertrophic cardiomyopathy

Speakers: Doctor M. Gawor, Mr C. Klein, Doctor L. Marques, Doctor L. Marques, Mrs A. Demkina...
Access
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb